(Q54257982)
Statements
A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma. A Southwest Oncology Group study. (English)
Zidar BL
Metch B
Balcerzak SP
Pierce HI
Militello L
Keppen MD
Berenberg JL
1 November 1992
70
10
2547-2551